Chargement en cours...
US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018
BACKGROUND/AIMS: The US Food and Drug Administration (FDA) outlines clinical studies as postmarketing requirements and commitments to be fulfilled following FDA approval of new drugs and biologics (“therapeutics”). Regulators have increasingly emphasized lifecycle evaluation of approved therapeutics...
Enregistré dans:
| Publié dans: | Clin Trials |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8292154/ https://ncbi.nlm.nih.gov/pubmed/33863236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17407745211005044 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|